Loading...
Market
Will the Biosecure Act face a legal challenge in U.S. courts by June 30, 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Court filings or public announcements of legal actions
Story
Congress Weighs Biosecure Act to Restrict Blacklisted Chinese Biotech Firms Over DNA Collection
Dec 5, 2024, 03:39 PM
The U.S. Congress is considering the Biosecure Act, a legislative measure aimed at restricting blacklisted Chinese biotechnology firms linked to the Chinese military from operating in the United States. These companies are allegedly collecting DNA data from American citizens and using it for military experiments, including the development of bio-weapons and complex viruses. The bill has passed the House of Representatives and now awaits Senate approval. Supporters of the bill argue that it is essential for safeguarding national security, economic independence, and preventing potential threats posed by Chinese military-linked entities. Lawmakers are reportedly exploring a potential compromise to advance the legislation.
View original story
Similar markets
No • 50%
Yes • 50%
Struck Down • 25%
No Challenge • 25%
Modified • 25%
Upheld • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
State Government • 25%
No Challenge Filed • 25%
Private Individual • 25%
Non-profit Organization • 25%
Partially upheld • 25%
Upheld • 25%
Struck down • 25%
Other • 25%
